Evangelos Terpos

53.8k total citations · 9 hit papers
869 papers, 23.7k citations indexed

About

Evangelos Terpos is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Evangelos Terpos has authored 869 papers receiving a total of 23.7k indexed citations (citations by other indexed papers that have themselves been cited), including 566 papers in Hematology, 418 papers in Oncology and 359 papers in Molecular Biology. Recurrent topics in Evangelos Terpos's work include Multiple Myeloma Research and Treatments (497 papers), Bone health and treatments (186 papers) and Protein Degradation and Inhibitors (134 papers). Evangelos Terpos is often cited by papers focused on Multiple Myeloma Research and Treatments (497 papers), Bone health and treatments (186 papers) and Protein Degradation and Inhibitors (134 papers). Evangelos Terpos collaborates with scholars based in Greece, United States and United Kingdom. Evangelos Terpos's co-authors include Meletios Α. Dimopoulos, Efstathios Kastritis, Ioannis Ntanasis‐Stathopoulos, Maria Gavriatopoulou, Ersi Voskaridou, Amin Rahemtulla, Μαρία Ρούσσου, Despina Fotiou, Θεοδώρα Ψαλτοπούλου and Lia A. Moulopoulos and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Evangelos Terpos

814 papers receiving 23.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hematological findings and complications of COVID‐19

2020 1.1k citations Evangelos Terpos, Ioannis Ntanasis‐Stathopoulos et al. American Journal of Hematology profile →
Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors

2005 858 citations Efstathios Kastritis, Lia A. Moulopoulos et al. Journal of Clinical Oncology profile →
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2017 518 citations Pieter Sonneveld, Meletios Α. Dimopoulos et al. profile →
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

2021 460 citations Meletios Α. Dimopoulos, Evangelos Terpos et al. profile →
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

2018 307 citations Evangelos Terpos et al. profile →
Bone health in cancer: ESMO Clinical Practice Guidelines

2020 294 citations Evangelos Terpos et al. profile →
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications

2021 182 citations Ioannis P. Trougakos, Evangelos Terpos et al. profile →
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis

2022 158 citations Ioannis P. Trougakos, Evangelos Terpos et al. profile →
Multiple myeloma

2024 72 citations Evangelos Terpos, Salomon Manier et al. profile →

Peers

Countries citing papers authored by Evangelos Terpos

Since Specialization

Citations

This map shows the geographic impact of Evangelos Terpos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos Terpos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos Terpos more than expected).

Fields of papers citing papers by Evangelos Terpos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evangelos Terpos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos Terpos. The network helps show where Evangelos Terpos may publish in the future.

Co-authorship network of co-authors of Evangelos Terpos

This figure shows the co-authorship network connecting the top 25 collaborators of Evangelos Terpos. A scholar is included among the top collaborators of Evangelos Terpos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelos Terpos. Evangelos Terpos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Role of the Bone Marrow Microenvironment in Physical Function and Quality of Life in Patients with Multiple Myeloma After First-Line Treatment with Novel Agents and Autologous Transplantation 2025 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Evangelos Eleutherakis‐Papaiakovou, (unknown), Nikolaos Kanellias, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Despina Fotiou, Evangelos Terpos, Vassilios Myrianthopoulos, Maria Gavriatopoulou, Ourania Tsitsilonis, Efstathios Kastritis, Meletios Α. Dimopoulos, Gerasimos Terzis	0
2	Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice 2025 ·Journal of Clinical Medicine ·Ioannis Ntanasis‐Stathopoulos, Vassilis Koutoulidis, Panagiotis Malandrakis, Despina Fotiou, (unknown), (unknown), (unknown), Nikolaos Kanellias, Foteini Theodorakakou, Evangelos Eleutherakis‐Papaiakovou, Efstathios Kastritis, Evangelos Terpos, Meletios Α. Dimopoulos, Lia A. Moulopoulos, Maria Gavriatopoulou	1
3	Upfront Anti-CD38 Monoclonal Antibody-Based Quadruplet Therapy for Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials 2025 ·Cancers ·Ioannis Ntanasis‐Stathopoulos, (unknown), Panagiotis Malandrakis, Vassilis Koutoulidis, Efstathios Kastritis, Evangelos Terpos, Meletios Α. Dimopoulos, Maria Gavriatopoulou	1
4	COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches 2024 ·Cell Communication and Signaling ·(unknown), Bahareh Hajikhani, (unknown), (unknown), Mohsen Nabi‐Afjadi, Marzieh Ramezani Farani, Hamidreza Zalpoor, Maryam Azarian, (unknown), Behrouz Gharesi‐Fard, Evangelos Terpos, Iman Zare, Mohammad Motamedifar	7
5	Sustained MRD Negativity for Three Years Can Guide Discontinuation of Lenalidomide Maintenance after ASCT in Multiple Myeloma: Results from a Prospective Cohort Study 2024 ·Blood ·Panagiotis Malandrakis, (unknown), Ioannis V. Kostopoulos, (unknown), Despina Fotiou, Foteini Theodorakakou, (unknown), Nikolaos Kanellias, Evangelos Eleutherakis‐Papaiakovou, Efstathios Kastritis, Maria Gavriatopoulou, Ourania Tsitsilonis, Meletios Α. Dimopoulos, Evangelos Terpos	2
6	A hypothesis on treatment strategy of severe multicentric Castleman disease with continuous renal replacement therapy 2024 ·Journal of Cellular and Molecular Medicine ·Cătălin Constantinescu, (unknown), Adrian Bogdan Țigu, Vlad Moisoiu, (unknown), Andrea Székely, Evangelos Terpos, (unknown)	2
7	Safety results from the phase 3 MajesTEC-7 study in patients (pts) with transplant ineligible/not intended newly diagnosed multiple myeloma (NDMM). 2024 ·Journal of Clinical Oncology ·Cyrille Touzeau, Meral Beksaç, Evangelos Terpos, Saad Z. Usmani, Amrita Krishnan, Inger S. Nijhof, Wojciech Janowski, Cyrille Hulin, Sebastian Grosicki, Michel Delforge, (unknown), Sarah Nagle, Yunsi Olyslager, Jonathan Miller, (unknown), Jamal Nasir Khan, Tobias Kampfenkel, Salomon Manier, Niels W.C.J. van de Donk	7
8	Evaluation of a novel method to guide belantamab mafodotin dosing in multiple myeloma based on a patient-reported questionnaire. 2024 ·Journal of Clinical Oncology ·Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, (unknown), (unknown), (unknown), (unknown), (unknown), Efstathios Kastritis, Meletios Α. Dimopoulos	2
9	Increased serum B‐cell maturation antigen levels evaluated with an Elecsys‐based serum B‐cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myeloma 2024 ·SHILAP Revista de lepidopterología ·Evangelos Terpos, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, (unknown), Evangelos Eleutherakis‐Papaiakovou, Foteini Theodorakakou, Μαρία Ρούσσου, Maria Gavriatopoulou, Meletios Α. Dimopoulos, Efstathios Kastritis	1
10	Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study 2023 ·Viruses ·(unknown), Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, (unknown), Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Efstathios Kastritis, Meletios Α. Dimopoulos, Evangelos Terpos	9
11	Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials 2023 ·Viruses ·(unknown), Ioannis Ntanasis‐Stathopoulos, (unknown), (unknown), Maria Gavriatopoulou, Θεοδώρα Ψαλτοπούλου, George Dounias, Theodoros Ν. Sergentanis, Evangelos Terpos	14
12	Chromosome 1q21 aberrations identify ultra high‐risk myeloma with prognostic and clinical implications 2022 ·American Journal of Hematology ·Efstathios Kastritis, Magdalini Migkou, (unknown), Maria Gavriatopoulou, Despina Fotiou, Μαρία Ρούσσου, Nikolaos Kanellias, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, (unknown), Evangelos Eleutherakis‐Papaiakovou, (unknown), Evangelos Terpos, Eirini Katodritou, Meletios Α. Dimopoulos	21
13	Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe 2022 ·Cancers ·Evangelos Terpos, Renato Zambello, Xavier Leleu, (unknown), Sorina Bădeliță, Eirini Katodritou, (unknown), (unknown), Sally Wetten, Jo Caers	5
14	Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group 2021 ·Journal of Clinical Medicine ·Jelena Bila, Eirini Katodritou, (unknown), Sandra Bašić‐Kinda, Daniel Coriu, (unknown), (unknown), (unknown), (unknown), Samo Zver, Meral Beksaç, Evangelos Terpos, Meletios Α. Dimopoulos	12
15	Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays 2021 ·Scientific Reports ·(unknown), (unknown), (unknown), Marianna Politou, Karolina Akinosoglou, Vaia Pliaka, (unknown), Evangelos Terpos, Ioannis P. Trougakos, Αndreas Mentis, Markos Marangos, George Panayiotakopoulos, Meletios Α. Dimopoulos, Charalampos Gogos, Alexandros Spyridonidis, Leonidas G. Alexopoulos	23
16	Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass. 2019 ·PubMed ·Athanasios D. Anastasilakis, Stergios A. Pοlyzos, Polyzois Makras, Martina Rauner, (unknown), Gerhard Hawa, Elena Tsourdi, Maria P. Yavropoulou, (unknown), Evangelos Terpos	0
17	The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016 2016 ·American Society of Clinical Oncology Educational Book ·Evangelos Terpos, Meletios Α. Dimopoulos, Lia A. Moulopoulos	31
18	Comparison of modern and conventional imaging techniques in establishing multiple myeloma‐related bone disease: a systematic review 2013 ·British Journal of Haematology ·Josien C. Regelink, Monique C. Minnema, Evangelos Terpos, Marjolein H. Kamphuis, Pieter G. Raijmakers, (unknown), Ben G. F. Heggelman, (unknown), René H.J. Otten, (unknown), Josée M. Zijlstra, Anne I.J. Arens, (unknown), Otto S. Hoekstra, Reinier Raymakers, Pieter Sonneveld, Raymond Ostelo, Sonja Zweegman	142
19	Survivin Messenger RNA Levels in Epstein-Barr Virus–Positive Patients With Leukemic Low-Grade B-Cell Lymphomas Expressing the Latent Membrane Protein 1: Evidence of Apoptotic Function? 2013 ·Clinical Lymphoma Myeloma & Leukemia ·Panagiotis Diamantopoulos, (unknown), (unknown), Marina Mantzourani, (unknown), Nikolaos Spanakis, Vasiliki Papadopoulou, Fani Kalala, Theodoros Iliakis, (unknown), (unknown), Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, Marina P. Siakantaris, Evangelos Terpos, (unknown), Panagoula Κollia, George Vaiopoulos, Gerassimos A. Pangalis, Nora‐Athina Viniou	2
20	The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS) 2009 ·Blood ·Ersi Voskaridou, Dimitrios Christoulas, Antonios Bilalis, Eleni Plata, Konstantinos Varvagiannis, G. Stamatopoulos, Klio Sinopoulou, (unknown), Dimitris Loukopoulos, Evangelos Terpos	307

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact